Detection of genes responsible for cetuximab sensitization in colorectal cancer cells using CRISPR-Cas9

Abstract Colorectal cancer (CRC) is a common malignant tumor in digestive tract with highly invasive and metastatic capacity. Drug sensitivity remains a significant obstacle to successful chemotherapy in CRC patients. The present study aimed to explore genes related to cetuximab (CTX) sensitivity in CRC by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9. Celigo image cytometer was used to detect suitable cells and optimal dosage of CTX. Inhibition rate of CTX on Caco-2 cells was evaluated by cell counting kit-8 (CCK-8) method before and after transfection. 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT) was performed to explore suitable concentration of puromycin and multiplicity of infection (MOI). CRISPR-Cas9, sequencing data quality analysis and cell viability test were used for the selection of genes related to CTX sensitivity in CRC cells. Finally, the selected genes associated with CTX sensitivity in CRC cells were further validated by colony formation and CCK-8 assays. In the present study, Caco-2 cells had a better prolificacy, and CTX 100 μg/ml exhibited a good inhibition trend on the 7th and 14th days of infection. MTT assay indicated that the minimum lethal concentration of puromycin was 2.5 μg/ml. Forty-six candidate genes were preliminarily screened via sequencing data quality analysis. Subsequently, we found that knockout of any of the four genes (MMP15, MRPL48, CALN1 and HADHB) could enhance CTX sensitivity in Caco-2 cells, which was further confirmed by colony formation assay. In summary, MMP15, MRPL48, CALN1 and HADHB genes are related to the mediation of CTX sensitivity in CRC.

[1]  Jian Yu,et al.  MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling , 2020, Advanced science.

[2]  M. Berchtold,et al.  The impact of calmodulin on the cell cycle analyzed in a novel human cellular genetic system. , 2020, Cell calcium.

[3]  R. Weinreb,et al.  Matrix Metalloproteinases and Glaucoma Treatment , 2020, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[4]  E. Dekker,et al.  Colorectal cancer , 2019, The Lancet.

[5]  Kwang-Hyun Cho,et al.  Systems analysis identifies potential target genes to overcome cetuximab resistance in colorectal cancer cells , 2019, The FEBS journal.

[6]  Y. Xi,et al.  MRPL35 Is Up-Regulated in Colorectal Cancer and Regulates Colorectal Cancer Cell Growth and Apoptosis. , 2019, The American journal of pathology.

[7]  E. Dronkers,et al.  Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable , 2019, Head & neck.

[8]  Daniel S. Chertow,et al.  CRISPR-Cas Biology and Its Application to Infectious Diseases , 2018, Journal of Clinical Microbiology.

[9]  Q. Le,et al.  Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results‐Medicare analysis , 2018, Cancer.

[10]  Xingyu Jiang,et al.  The construction of drug-resistant cancer cell lines by CRISPR/Cas9 system for drug screening. , 2018, Science bulletin.

[11]  Shukui Wang,et al.  Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer , 2018, Cancer management and research.

[12]  Yanmin Zhang,et al.  Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer , 2018, Advanced science.

[13]  Julia M. Shifman,et al.  Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP-9 and MMP-14 , 2017, bioRxiv.

[14]  B. Robert,et al.  Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer , 2018, EMBO molecular medicine.

[15]  Ying Peng,et al.  A CRISPR reimagining: New twists and turns of CRISPR beyond the genome‐engineering revolution , 2018, Journal of cellular biochemistry.

[16]  Yan Qin,et al.  mir-106a regulates cell proliferation and apoptosis of colon cancer cells through targeting the PTEN/PI3K/AKT signaling pathway. , 2017, Oncology letters.

[17]  A. Florea,et al.  Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview , 2017, Cancers.

[18]  Wei Shen,et al.  MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma , 2017, International journal of molecular medicine.

[19]  V. Gebski,et al.  Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Neville E Sanjana,et al.  Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening , 2016, Nature Protocols.

[21]  D. Neumann,et al.  Molecular mechanism of lipid-induced cardiac insulin resistance and contractile dysfunction. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  C. Blanpain,et al.  Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.

[23]  Konstantin Severinov,et al.  Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3′-terminal segment of guide RNA , 2016, Nucleic acids research.

[24]  Chih-Yang Huang,et al.  Plasma levels of matrix metalloproteinase-2 and -9 in male and female patients with cirrhosis of different aetiologies , 2015, Journal of Clinical Pathology.

[25]  Ronald J A Wanders,et al.  Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene. , 2006, Clinical chemistry.

[26]  M. Jamrich,et al.  Identification of a human brain-specific gene, calneuron 1, a new member of the calmodulin superfamily. , 2001, Molecular genetics and metabolism.

[27]  M. Wheatley,et al.  CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application. , 2017, Progress in molecular biology and translational science.

[28]  K. Dede,et al.  Pathologic Assessment of Response to Chemotherapy in Colorectal Cancer Liver Metastases after Hepatic Resection: Which Method to Use? , 2014, Pathology & Oncology Research.

[29]  Catherine B. Chan,et al.  Gene and protein kinase expression profiling of reactive oxygen species-associated lipotoxicity in the pancreatic beta-cell line MIN6. , 2004, Diabetes.